Drug Approval | March 01, 2024
Biocon Biologics secures US market entry date for Bmab 1200
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
_Rupak_Singla_256_384.jpg)
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
We are achieving the target of developed India by making our young children healthy today
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Subscribe To Our Newsletter & Stay Updated
